REQUEST – FCF LIFE SCIENCES RESEARCH SERIES

FCF Life Sciences engages in research on recent financing trends in the Life Sciences sector, i.e. biotechnology, pharma and med-tech. FCF primarily focuses on the latest activities in the equity capital markets: Venture Capital, Initial Public Offerings (IPO) and Equity Valuations.

The findings are regularly published in

Bitte füllen Sie das Pflichtfeld aus.

Salutation

Bitte füllen Sie das Pflichtfeld aus.

Titel

Like Dr., Prof. ...

Bitte füllen Sie das Pflichtfeld aus.

First name

Bitte füllen Sie das Pflichtfeld aus.

Last name

Bitte füllen Sie das Pflichtfeld aus.

E-Mail

Bitte füllen Sie das Pflichtfeld aus.

Position

Bitte füllen Sie das Pflichtfeld aus.

Company

Consent to be contacted

FCF Fox Corporate Finance GmbH (FCF) uses the information in this form to stay in touch with you and to inform you about events and latest market analyses.

Please fill mandatory field

Yes, I agree to be contacted by FCF.*

Bitte füllen Sie das Pflichtfeld aus.

Yes, I agree that FCF can contact me via E-Mail for the purposes of data maintenance.

I agree that for the stated purposes my data will be electronically processed by FCF. I can revoke this consent at any moment in time - without reasoning - and cancel the receipt of the FCF News with immediate effect. FCF will treat my data confidentially and will not disclose it to third parties.

Please fill mandatory field

Yes, I agree with the data protection provisions of FCF.

Learn more about our privacy policy.
* Mandatory fields

** All information and market analyses published by FCF are exclusively directed to and for the use by current and potential institutional clients, partners and investors. FCF retains the right to reject your request. To verify your request, we therefore need qualified details for the required fields.

NEWS & PRESS

Venture Capital Sentiment Tracker – October 2023

October 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend

November 30, 2023

thumbnail of 2023-11-22 – FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10-2023

FCF Healthcare & Life Sciences Venture Capital Monitor – Europe – 10/2023 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Healthcare & Life Sciences Venture Capital Monitor – Europe 10/2023”. The Monitor is a monthly published overview of venture capital trends in the European

November 27, 2023

Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million.

PRESS RELEASE Munich-based Financing Specialist FCF Fox Corporate Finance advises Dutch Agricultural Technology Innovator In Ovo in a pivotal funding round of EUR 40 Million. Munich, November 6, 2023 – FCF Fox Corporate Finance, a

November 6, 2023

thumbnail of 2023-10-09 – Biotech Venture Capital Monitor – USA – 09-2023

FCF Biotech Venture Capital Monitor – USA 09/2023 published

FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 09/2023”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As

October 18, 2023

Venture Capital Sentiment Tracker – September 2023

September 2023: Biotechnology Medical Technology Health Technology Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Funding Volume (€m) 0 Trend Biotechnology Funding Volume (€m) 0 Trend Medical Technology Funding Volume (€m) 0 Trend

October 16, 2023